Current Total Available Market (TAM) is USD $118 million dollars per annum, meaning that LDX have a unique product which is of global importance and now have USA government support in terms of cost reimbursement for the use for their product.
IMO, and as the article posted below states, "if there is positive incentive for adoption such as the clinician or the facility getting paid then they will use the product".
Current TAM is USD $118 million dollars per annum which is massive and IMO will translate to an immediate and significant uptick in sales........but the crazy thing is that after the CLIA waiver the TAM will be USD $ 1.7 BILLION per annum.
IMO LDX is significantly undervalued.
=)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.21M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 318288 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 45000 | 2 |
View Market Depth
| Last trade - 09.45am 18/06/2025 (20 minute delay) ? |
| LDX (ASX) Chart |
Day chart unavailable